Introduction
Invasive breast carcinoma (IBC) is a heterogeneous disease, with more than 20 distinct histologic types recognized by the World Health Organization (WHO) classification (1) . In addition to immunohistochemical (IHC) methods, molecular techniques have yielded information on the genetic characteristics of IBC 
Triple negative breast cancer (TNBC)
TNBC is characterized by the lack of ER, PR and HER2 expression by IHC analysis (10), constitutes 10%-20% of all breast cancers (11) , occurs more frequently in younger patients (11, 12, 13) , is associated with a higher tumour grade and a higher risk of distant recurrence and disease-related mortality within the first 3-5 years after diagnosis (14, 15) . TNBC, similar to the basal-like breast carcinoma (BLBC) in the GEP molecular classification, shows a significantly shorter survival following the first metastatic event when compared with those with non-basal-like/non-triple-negative controls (16, 17) . Histologically, TNBC is heterogeneous and encompasses many different histologic subtypes in the current WHO classification.
TNBCs may appear as infiltrating duct carcinoma no special subtype, carcinoma associated with BRCA-1 mutations, carcinoma with medullary features, pleomorphic lobular carcinoma and apocrine carcinoma. In addition TNBC can also be low grade and associated with good prognosis, and includes rare tumours like adenoid cystic carcinoma and secretory carcinoma. In addition, it has been shown that there is significant intratumoral heterogeneity in TNBC (18) . These evidence indicated that TNBC should not be treated as a single disease, but a group of diseases with different biologic behavior. Further sub-classification and evaluation of novel markers may be useful in better defining TNBC and for their accurate prognostication, and potential treatment strategies. 
Molecular classification of TNBC

Additional markers relevant to TNBC classification and prognostication Ki67
Ki67 is a nuclear antigen which is expressed in the cell cycle except the G 0 phase.
Ki67 IHC staining has been used for measuring and monitoring tumor proliferation in standard pathology specimens (21 in AR-, ER-/PR-metastatic BC (29).
Tumour-infiltrating lymphocytes (TIL)
It is increasingly recognized that cancers are not merely autonomous masses of mutant cells, rather it is a disease encompassing multiple components of tumor cells and host stromal cells (30) . showing better metastasis-free survival (36) . 
Relationship with basal-like breast cancer (BLBC)
Alpha B-crystallin
Alpha B-crystallin functions as a member of the conserved small heat shock protein which confers protection against a broad range of apoptotic stimuli (41) . Alpha B-crystallin expression is restricted to myoepithelial cells in normal breast tissue, proliferative lesions and in situ IBCs (42) . Cytoplasmic expression of αBcrystallin is demonstrated on most basal-like and metaplastic cancers (42, 43) , in addition to other epithelial tumors (44) . Consistent αBcrystallin gene expression is also detected in BLBC cluster from microarray studies (45) . In IBCs, expression of αB-crystallin is associated also with lymph node involvement (39), shorter disease specific survival (45) , and poorer overall response rates to neo-adjuvant chemotherapy (46) . 
